PMGC Holdings (ELAB) Total Debt (2022 - 2026)
PMGC Holdings' (ELAB) quarterly Total Debt came in at $9.8 million in Q2 2026, up 25.46% quarter-over-quarter from $7.8 million in Q1 2026.
Analysis
PMGC Holdings (ELAB) Total Debt (2022 - 2026) Analysis & Trends
PMGC Holdings has disclosed Total Debt across 5 years of filings, most recently posting $9.8 million for Q2 2026.
- In Q2 2026, Total Debt changed N/A year-over-year to $9.8 million; the TTM figure through Jun 2026 stood at $9.8 million (changed N/A YoY), while the FY2025 annual figure was $1.8 million, changed N/A from the prior year.
- Total Debt came in at $9.8 million for Q2 2026 at PMGC Holdings, up from $7.8 million in the prior quarter.
- In the past five years, Total Debt ranged from a high of $519.5 million in Q3 2023 to a low of $68455.0 in Q4 2022.
- Average Total Debt over 5 years is $54.7 million, with a median of $1.5 million recorded in 2024.
- Year-over-year, Total Debt surged 551.94% in 2023 and plunged 99.76% in 2024.
- Over 5 years, Total Debt stood at $68455.0 in 2022, then surged by 551.94% to $446285.0 in 2023, then surged by 182.17% to $1.3 million in 2024, then soared by 39.59% to $1.8 million in 2025, then jumped by 458.59% to $9.8 million in 2026.
- Per Business Quant data, the three most recent Total Debt figures were $9.8 million in Q2 2026, $7.8 million in Q1 2026, and $1.8 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.40 Bn | 192.42 Bn | 7.24 Bn | 62.75 Bn |
| 2 | Gilead Sciences | 180.38 Bn | 177.20 Bn | 6.22 Bn | 28.66 Bn |
| 3 | Vertex Pharmaceuticals | 131.28 Bn | 123.43 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 81.73 Bn | 73.73 Bn | 3.93 Bn | 1.99 Bn |
| 5 | Argenx Se | 60.28 Bn | 55.09 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.02 Bn | 48.88 Bn | 52.00 Mn | 591.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.28 Bn | 29.97 Bn | 992.69 Mn | - |
| 8 | Biogen | 31.81 Bn | 30.52 Bn | 1.96 Bn | 8.09 Bn |
| 9 | Roivant Sciences | 29.02 Bn | 29.02 Bn | 1.16 Mn | - |
| 10 | PMGC Holdings | 2.29 Mn | -16.50 Mn | 385,691.00 | 9.82 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 9.82 Mn |
| Mar 31, 2026 | 7.83 Mn |
| Dec 31, 2025 | 1.76 Mn |
| Sep 30, 2025 | 3.88 Mn |
| Sep 30, 2024 | 1.26 Mn |
| Jun 30, 2024 | 1.27 Mn |
| Mar 31, 2024 | 924,665.00 |
| Dec 31, 2023 | 446,285.00 |
| Sep 30, 2023 | 519.51 Mn |
| Dec 31, 2022 | 68,455.00 |